Led · Equity · Mar 2026

Verily builds an AI-native precision health platform that transforms multimodal health data into insights, models, and actions intended to make healthcare more personalized, predictive, and precise. The company plans to accelerate that platform strategy following a $300 million investment and a legal restructure from an LLC to Verily Health Inc. Verily has been expanding commercial relationships—announcing collaborations with Samsung’s Galaxy Watch, Salesforce, UCHealth, the University of Colorado Anschutz, and RefinedScience—for biomarker development, clinical research acceleration, and enterprise precision health solutions. Alphabet remains an investor and, after the round, holds a significant minority position rather than a controlling stake. The company positions itself at the intersection of technology, data science, and healthcare to drive AI-enabled research and care transformation.

Participated · Equity · Mar 2026

Anori aims to unify parties involved in the two-to-four year pre-development window—developers, architects, engineers, regulators and financiers—to surface compliance conflicts much faster. Its initial product focus is three-to-six-story multifamily buildings of roughly 5 to 100 units, with other project types such as hospitals and data centers also contemplated. Anori was founded inside X in fall 2023 and is led by CEO Adrian Walker, who joined X after a decade in the Bay Area and prior experience at Ford Motor Company. The company has secured a partnership with Rio de Janeiro to modernize the city’s permitting process, though no building has yet been approved through the platform. Anori’s strategy emphasizes industry-led development of the product, with major real estate and construction firms invested to incentivize adoption and integration.